Your browser is no longer supported. Please, upgrade your browser.
Settings
SGYP Synergy Pharmaceuticals Inc. daily Stock Chart
SGYP [NASD]
Synergy Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.17 Insider Own0.20% Shs Outstand224.95M Perf Week-4.07%
Market Cap582.62M Forward P/E- EPS next Y-0.66 Insider Trans-3.04% Shs Float224.03M Perf Month-13.38%
Income-238.60M PEG- EPS next Q-0.27 Inst Own73.60% Short Float30.16% Perf Quarter-45.36%
Sales2.40M P/S242.76 EPS this Y-8.50% Inst Trans5.76% Short Ratio15.39 Perf Half Y-43.33%
Book/sh0.19 P/B13.63 EPS next Y42.10% ROA-202.70% Target Price9.86 Perf Year-53.58%
Cash/sh- P/C- EPS next 5Y- ROE-485.00% 52W Range2.57 - 7.15 Perf YTD-57.47%
Dividend- P/FCF- EPS past 5Y-31.80% ROI- 52W High-63.78% Beta1.41
Dividend %- Quick Ratio2.10 Sales past 5Y- Gross Margin-94.70% 52W Low0.78% ATR0.14
Employees116 Current Ratio2.30 Sales Q/Q- Oper. Margin- RSI (14)27.18 Volatility3.43% 5.20%
OptionableYes Debt/Eq0.39 EPS Q/Q-43.20% Profit Margin- Rel Volume1.18 Prev Close2.64
ShortableYes LT Debt/Eq0.39 EarningsAug 14 AMC Payout- Avg Volume4.39M Price2.59
Recom2.00 SMA20-9.22% SMA50-22.72% SMA200-43.32% Volume5,166,584 Change-1.89%
Sep-13-17Reiterated Citigroup Sell $3.20 → $2.50
Sep-08-17Reiterated Oppenheimer Outperform $9 → $6
Aug-10-17Reiterated Rodman & Renshaw Buy $18 → $15
Apr-06-17Downgrade Citigroup Neutral → Sell
Jan-20-17Reiterated Rodman & Renshaw Buy $17 → $18
Jan-05-17Initiated Oppenheimer Outperform
Dec-23-16Reiterated Rodman & Renshaw Buy $16 → $17
Dec-18-15Downgrade Citigroup Buy → Neutral
Oct-29-15Resumed ROTH Capital Buy $9.50
Jun-18-15Reiterated Canaccord Genuity Buy $11 → $19
May-22-15Initiated Canaccord Genuity Buy $11
Nov-18-14Reiterated ROTH Capital Buy $8.50 → $6
Aug-12-13Reiterated Cantor Fitzgerald Buy $15 → $11
Apr-09-13Reiterated Cantor Fitzgerald Buy $12 → $15
Jan-02-13Reiterated Cantor Fitzgerald Buy $7 → $13
Sep-25-12Initiated Cantor Fitzgerald Buy $7
Sep-21-17 07:54PM  CORRECTING and REPLACING Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences Business Wire
Sep-08-17 09:45PM  Edited Transcript of SGYP earnings conference call or presentation 7-Sep-17 8:30pm GMT Thomson Reuters StreetEvents -7.31%
Sep-06-17 08:30AM  Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences Business Wire
08:00AM  2017 is a Transformative Year for Synergy, Q2 Review, and Analyst Outlook ACCESSWIRE
Sep-05-17 08:30AM  Synergy Pharmaceuticals Secures $300 Million Debt Financing Business Wire
Aug-11-17 08:40PM  Synergy Pharmaceuticals, Inc. Value Analysis (NASDAQ:SGYP) : August 12, 2017 Capital Cube
Aug-10-17 11:19AM  Here's Why Synergy Pharmaceuticals Inc. Is Falling Today Motley Fool -13.03%
08:05AM  IHS Markit Score Update: Drop in demand for ETFs holding Synergy Pharmaceuticals Inc is a negative sign for its shares Markit
Aug-09-17 04:30PM  Synergy Pharmaceuticals Reports Second Quarter 2017 Financial Results and Business Update Business Wire
Aug-08-17 02:58PM  Synergy Pharmaceuticals Inc. Tanked 14.2% in July -- but Why? Motley Fool -7.27%
Jul-28-17 09:35AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SGYP-US : July 28, 2017 Capital Cube
Jul-25-17 01:11PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : July 25, 2017 Capital Cube
Jul-24-17 07:09PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : July 24, 2017 Capital Cube
Jul-14-17 04:48PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : July 14, 2017 Capital Cube
Jul-13-17 04:07PM  What To Expect Ahead of Synergy Pharmaceuticals Inc (SGYP) 2Q Earnings; Oppenheimers Take SmarterAnalyst
Jul-10-17 01:41PM  Synergy Pharmaceuticals Inc (SGYP) Trulance Poses Enticing Long-Term Uptake SmarterAnalyst
Jun-27-17 11:55AM  Healthcare Guru Samuel Isaly Plays Two Key Biotech Stocks: Synergy Pharmaceuticals Inc (SGPY), Gilead Sciences, Inc. (GILD) SmarterAnalyst -5.18%
Jun-26-17 06:41PM  Synergy Pharmaceuticals Incs (SGYP) CIC Drug Set To Stay In Spotlight; BTIG Weighs In SmarterAnalyst
Jun-20-17 03:42PM  Why This Billionaire Just Bought Gilead Sciences, Synergy, and Valeant Stock Motley Fool
Jun-15-17 03:17PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : June 15, 2017 Capital Cube
Jun-14-17 02:18PM  Synergy Pharmaceuticals, Inc. Value Analysis (NASDAQ:SGYP) : June 14, 2017 Capital Cube
Jun-13-17 08:37AM  Rodman & Renshaw Roots for Synergy Pharmaceuticals Inc. (SGYP) Ahead of Promising Commercial Trajectory for Trulance SmarterAnalyst
08:26AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SGYP-US : June 13, 2017 Capital Cube
Jun-12-17 12:40PM  Billionaire Israel Izzy Englander Bets on Three Biotech Stocks: Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD), Synergy Pharmaceuticals Inc (SGYP) SmarterAnalyst
Jun-07-17 09:00AM  Synergy Pharmaceuticals Announces Acceptance of Supplemental New Drug Application (sNDA) for TRULANCE (Plecanatide) for the Treatment of Adults with Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
Jun-05-17 09:01AM  Is Ironwood's Growth About to Slow? Motley Fool -5.25%
08:00AM  Today's Research Reports on Stocks to Watch: Synergy Pharmaceuticals and Bioscrip Inc. Accesswire
Jun-03-17 11:13AM  Here's the Volatile Biotech Stock One Analyst Thinks Could Boom 175% TheStreet.com
Jun-02-17 01:03PM  Why Synergy Pharmaceuticals Shares Are Popping 16.7% Today Motley Fool +10.19%
May-30-17 08:30AM  Synergy Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference Business Wire
May-29-17 01:32PM  With Ardelyx's Fall, Does Synergy Now Have a Clear Path to Victory? Motley Fool
May-17-17 10:01AM  Allergan's Irritable Bowel Drug Viberzi Approved in Canada Zacks -6.33%
May-15-17 04:59PM  What Do the Ardelyx Numbers Mean for the Company? GuruFocus.com -8.31%
08:00AM  Synergy Pharmaceuticals and Durect Corporation Both Sail Higher on Trader Optimism Accesswire
May-10-17 06:44PM  Synergy Pharma reports 1Q loss Associated Press
04:54PM  Synergy Pharmaceuticals Reports First Quarter 2017 Financial Results and Business Update Business Wire
May-09-17 11:46AM  Synergy Scores Again: Trulance Product Meets Phase 3 Endpoints In Second Indication Benzinga
11:45AM  Synergy Pharmaceuticals to Present Positive TRULANCE (Plecanatide) Phase 3 Data at Digestive Disease Week (DDW) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
May-07-17 10:30AM  Synergy Presents New Insights at Digestive Disease Week (DDW) Examining Patient and Physician Perceptions and Experiences with Chronic Idiopathic Constipation (CIC) Business Wire
10:30AM  Synergy Pharmaceuticals to Present TRULANCE (Plecanatide) Phase 3 Data at Digestive Disease Week (DDW) for the Treatment of Adults with Chronic Idiopathic Constipation (CIC) with Moderate to Very Severe Bloating Business Wire
May-01-17 08:00AM  Synergy Pharmaceuticals to Highlight New Data for TRULANCE (Plecanatide) at Digestive Disease Week (DDW) Business Wire
Apr-24-17 08:00AM  Synergy Pharmaceuticals to Present at the 42nd Annual Deutsche Bank Healthcare Conference Business Wire
Apr-17-17 08:00AM  Synergy Pharmaceuticals Appoints Gary G. Gemignani as Chief Financial Officer Business Wire
Apr-13-17 09:21AM  Biotech Movers: Synergy, Biogen, Insys TheStreet.com
Apr-12-17 09:32AM  Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents TheStreet.com
08:00AM  Synergy Pharmaceuticals Announces Issuance of Three New Patents Expected to Extend TRULANCE (Plecanatide) Patent Protection Until 2032 Business Wire
Apr-06-17 08:46PM  [$$] Overheard The Wall Street Journal -5.32%
10:56AM  Drug Company's New Poop Emojis Make a Splash The Wall Street Journal
10:32AM  Trevena, Synergy Lead Biotech Movers TheStreet.com
09:06AM  Synergy Pharmaceuticals Launches the Poop Troop, the First Emoji Keyboard Designed to Support Dialogue Around Chronic Idiopathic Constipation (CIC) Business Wire
Mar-30-17 07:14AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Synergy Pharmaceuticals Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Mar-27-17 08:31AM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Synergy Pharmaceuticals Submits Supplemental New Drug Application (sNDA) for TRULANCE (Plecanatide) for the Treatment of Adults with Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
Mar-21-17 02:46PM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -8.64%
Mar-14-17 09:32AM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  Synergy Pharmaceuticals to Present at Oppenheimer 27th Annual Healthcare Conference Business Wire
Mar-13-17 09:29AM  Synergy Pharmaceuticals: Approval, Now What? Motley Fool
Mar-07-17 01:04PM  SYNERGY PHARMACEUTICALS, INC. Financials
Mar-02-17 04:45PM  CORRECTING and REPLACING Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update Business Wire -5.46%
04:02PM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Mar-01-17 05:15PM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
05:12PM  Synergy Pharma reports 4Q loss Associated Press
04:42PM  Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update Business Wire
Feb-23-17 11:07AM  Did 50 Salespeople Leave Valeant? Wells Fargo Investigates Barrons.com
10:07AM  Why President Trump Wants To Transform The FDA And What It Could Mean For Biotech Stocks at Insider Monkey
Feb-15-17 10:37AM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-08-17 10:42AM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  Synergy Pharmaceuticals to Present at Leerink Partners 6th Annual Global Healthcare Conference Business Wire
Feb-07-17 12:31PM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:30AM  Pivotal Phase 3 Data Results for TRULANCE (plecanatide) in the Treatment of Chronic Idiopathic Constipation (CIC) Published in American Journal of Gastroenterology Business Wire
Feb-03-17 06:22AM  Price For Synergy Pharmaceuticals Inc (SGYP) Public Offering Announced at Insider Monkey
Feb-02-17 04:44PM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
Feb-01-17 05:46PM  Why Synergy Pharmaceuticals Shares Fell 14.6% Today at Motley Fool -14.57%
12:18PM  How to Trade Hot Stocks Apple, Seadrill, Advanced Micro Devices
09:50AM  Fail, win and then fail some more to become a winning trader
09:30AM  The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Amgen, Valeant Pharmaceuticals International, Celgene and Lexicon Pharmaceuticals
09:23AM  Premarket Biotech Movers: Synergy, Arrowhead, BioCryst
08:17AM  Synergy Pharma stock sinks 12.5% after announcement of common stock offering at MarketWatch
08:00AM  Synergy Pharmaceuticals Announces Pricing of Public Offering of Common Stock Business Wire
Jan-31-17 04:01PM  Synergy Pharmaceuticals Announces Proposed Public Offering of Common Stock Business Wire +8.10%
06:43AM  4 FDA Decisions to Watch Out for in Feb 2017
Jan-26-17 04:28PM  5 Small-Cap Biotech Stocks to Buy in February at Motley Fool
Jan-25-17 10:09AM  FDA Approves Trulance From Synergy Pharmaceuticals Inc (SGYP) To Battle With Allergan PLC (AGN) Linzess at Insider Monkey
Jan-24-17 11:23AM  UPDATE 1-Synergy wins U.S. approval for constipation drug (Jan 19) Reuters
08:32AM  Are Options Traders Betting on a Big Move in Synergy Pharmaceuticals (SGYP) Stock?
Jan-23-17 01:00AM  Bristol-Myers Squibb, Merck, Synergy Pharmaceuticals: Doug Kass' Views
Jan-20-17 10:37AM  Synergy Pharmaceuticals Secures Approval for Linzess Competitor -7.80%
09:37AM  FDA OKs Synergy Pharmaceuticals Constipation Drug at Investopedia
08:38AM  Synergy (SGYP) Trulance Wins FDA Approval for Constipation
06:03AM  SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-19-17 07:27PM  Synergy Pharmaceuticals TRULANCE (Plecanatide) Receives U.S. FDA Approval for the Treatment of Adults with Chronic Idiopathic Constipation Business Wire
04:34PM  Synergy wins U.S. approval for constipation drug Reuters
Jan-18-17 09:26AM  5 Biotech Stocks You'll Want to Watch in the 1st Quarter at Motley Fool
Jan-17-17 09:25AM  Synergy Pharmaceuticals Inc (SGYP): A Top January Pick Ahead Of PDUFA at Insider Monkey
08:28AM  Key FDA Events to Watch Out for in Q1
Jan-12-17 03:54PM  3 Little-Known Pharmaceutical Companies to Put on Your Radar at Motley Fool
Jan-09-17 11:11AM  Start the New Year off Right with 3 Best Biotech Stocks at Motley Fool
Jan-06-17 06:57PM  The most speculative stock in the world that everyone wants Jim Cramer to pound the table on at CNBC
10:25AM  6 Major FDA Decisions and Biopharma Catalysts Coming in January and February
07:28AM  5 Stocks to Play on New Analyst Coverage
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its lead product is plecanatide, a novel uroguanylin analog that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel syndrome. The company also develops dolcanatide to treat mild-to-moderate ulcerative colitis. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PAULSON & CO. INC.10% OwnerAug 07Sale3.7726,28798,97224,062,368Aug 09 06:17 PM
BRANCACCIO JOHN PDirectorMay 26Buy3.596,50023,33530,444May 30 07:56 AM
JACOB GARY SChief Executive OfficerMay 26Buy3.525,68019,967402,679May 30 07:55 AM
PAULSON & CO. INC.10% OwnerNov 04Sale4.24140,000593,93624,088,655Nov 08 04:44 PM
PAULSON & CO. INC.10% OwnerSep 28Sale5.6020,700116,00524,228,655Sep 29 05:22 PM
PAULSON & CO. INC.10% OwnerSep 27Sale5.7533,600193,05924,249,355Sep 29 05:22 PM